Compugen (CGEN) Reports In-Line Q4 EPS

Compugen (NASDAQ: CGEN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
• Standard Uranium closes first tranche of private placement at $0.10
• Cinemark Holdings (CNK) Reiterated at Buy by Benchmark as Q2 Estimates Raised